Skip to main content

Day: September 14, 2022

America First Multifamily Investors, L.P. Announces Regular Quarterly Cash Distribution and Supplemental BUCs Distribution

OMAHA, Neb., Sept. 14, 2022 (GLOBE NEWSWIRE) — On September 14, 2022, America First Multifamily Investors, L.P. (NASDAQ: ATAX) (the “Partnership” or “ATAX”) announced that the Board of Managers of Greystone AF Manager LLC (“Greystone Manager”) declared a distribution to the Partnership’s Beneficial Unit Certificate (“BUC”) holders of $0.57 per BUC. The distribution consists of a regular quarterly cash distribution of $0.37 per BUC plus a supplemental distribution payable in the form of additional BUCs equal in value to $0.20 per BUC. The supplemental distribution will be paid at a ratio of 0.01044 BUCs for each issued and outstanding BUC as of the record date, which represents an amount per BUC based on the closing price of the BUCs on the Nasdaq Stock Market LLC on September 13, 2022 of $19.15 per BUC. No fractional BUCs will...

Continue reading

Golden Triangle Ventures, Inc. Announces New CEO for Global Health Services Operating Under Its Health Division

LAS VEGAS, Sept. 14, 2022 (GLOBE NEWSWIRE) — — via InvestorWire — Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTV” or the “Company”) is proud to announce that Global Health Services, Inc., operating under the company’s Health Division, has appointed a new CEO, Dr. Dan Jurgens, to assist the business in executing its current business strategy while developing new opportunities to help achieve the company’s overarching goals. Dr. Jurgens graduated from the University of Manitoba with a degree in Physical Education and Recreational Studies in 1996. Originally from Manitoba, Canada, Dr. Jurgens transitioned to California and graduated in 2001 with a Chiropractic Doctorate (D.C.) from Life West Chiropractic College. Dr. Jurgens is an entrepreneur at heart and immediately started his own chiropractic clinic in San Diego,...

Continue reading

KULR Technology Joins NAATBatt, the Premiere Trade Association for Advanced Battery Technology

SAN DIEGO, Sept. 14, 2022 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leading developer of next-generation lithium-ion (“Li-ion”) battery safety and thermal management technologies, today announced it has joined NAATBatt International (NAATBatt), the premiere trade association of developers, manufacturers, suppliers and users of battery technology in North America. As a platinum member, KULR will regularly participate in board meetings, allowing the company to connect with top policy makers in the space, discuss and develop cutting-edge technological advancements and remain at the forefront of battery technology. “KULR is at an inflection point as we position our thermal safety solutions platform to become further entrenched in the marketplace, ultimately...

Continue reading

US Nuclear: Demand for Radiation Safety Equipment Surges

LOS ANGELES, CA, Sept. 14, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Radiation measurement and safety equipment is no longer the niche market it used to be.  With the ongoing threat of a nuclear disaster in Ukraine, new nuclear power plants being built across the world to curb energy demand and prices and prevent climate change, the urgent need to mine more uranium for nuclear power production, the huge number of nuclear fusion energy prototypes—demand for radiation safety and protection equipment is through the roof—and US Nuclear Corp. (OTC-QB: UCLE) is at the forefront of the surging market.  Furthermore, the Inflation Reduction Act (IRA) signed recently by President Biden, is a game changer for the US nuclear energy sector, guaranteeing a commitment to nuclear energy that will continue well past the journey to net-zero carbon.  The...

Continue reading

GIMOTI Receives Nomination for 2022 Healio Industry Breakthrough Award

GIMOTI recognized as a major disruptor in the gastroenterology field, including several large global pharmaceutical companies Vote for GIMOTI as 2022 Healio Industry Breakthrough Product via Survey SOLANA BEACH, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced that its flagship product, GIMOTI has been nominated for Healio’s Annual Disruptive Innovators Awards under the Healio Industry Breakthrough Award category. GIMOTI was selected amongst other novel gastroenterology products from major pharmaceutical companies. Healio is an online source for in-depth specialty clinical information featuring the industry’s best news reporting,...

Continue reading

Marketing Agency Headline Athens Purchases ARHT Media’s CAPSULE Technology to Showcase its Clients at the 86th Annual Thessaloniki International Fair

Marketing Agency Headline Athens Purchases ARHT Media’s CAPSULE Technology to Showcase its Clients at the 86th Annual Thessaloniki International Fair Headline Athens has purchased ARHT’s CAPSULE hologram display to begin offering hologram technology as a solution for their clients who are seeking to deploy new and unique interactive experiences that merge the physical world with the digital.TORONTO, Sept. 14, 2022 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT Media” or “ARHT” or the “Company“) [TSXV:ART], the global leader in the development, production and distribution of high-quality and low-latency hologram and digital content, announced today that experiential marketing agency Headline Athens has purchased ARHT’s CAPSULE hologram display to begin offering hologram technology as a solution for their clients...

Continue reading

Powersports Market Size Worth USD 12.75 Billion, Globally, by 2027 at 5.5% CAGR

The global powersports market size is projected to grow from USD 9.44 billion in 2019 to USD 12.75 billion in 2027 at a CAGR of 5.5% in the 2021-2027 period. Increasing demand for ATVs worldwide to boost the market growth in forecast period of 2021-2027. Pune, India, Sept. 14, 2022 (GLOBE NEWSWIRE) — The global powersports market size is projected to reach USD 12.75 billion by the end of 2027. Factors such as the growing demand for ATVs and the increasing focus of the manufacturers to expand their facilities will propel the demand for the product. According to a report published by Fortune Business Insights, titled “Powersports Market Size, Share & COVID-19 Impact Analysis, By Vehicle Type (All-Terrain Vehicle, Side-by-Side Vehicle, Personal Watercraft, Snowmobiles, Heavyweight Motorcycle), By Application (On-Road, Off-Road),...

Continue reading

Pet Tech Market to Hit Sales of $17.57 Billion by 2028 | RFID Chips Generates 30% Market Revenue

Global pet tech market was valued at $5.2 billion in 2021, and it is expected to attain a value of $17.57 billion by 2028, with a CAGR of 19% over the projection period (2022–2028). Westford, USA, Sept. 14, 2022 (GLOBE NEWSWIRE) — The demand for smart devices for pets is on the rise, as people look to enhance their companions’ lives by providing them with devices that can relay information like location, temperature, and pet activity. According to SkyQuest’s recent study on global pet tech market, over 52% of American adults own a smart device for their pet. In Europe, the figure is even higher at 67%. This increasing demand is likely due to several factors. First, there is a growing trend of people adopting pets who are older or have special needs, which creates an opening for devices that can improve the quality of life...

Continue reading

Upcoming Presentation at Joint Meeting of ISBRA and ESBRA to Highlight Potential of Hepion Pharmaceutical’s Rencofilstat to Treat Alcohol-Related Liver Disease

EDISON, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver diseases, today announced that its research collaborators from London’s Institute of Hepatology will present new findings on the Company’s cyclophilin inhibitor, rencofilstat, in an awarded oral presentation at the 2022 joint meeting of the International Society for Biomedical Research on Alcoholism (ISBRA) and European Society for Biomedical Research on Alcoholism (ESBRA), taking place September 17-20, 2022 in Cracow, Poland. Alcohol-associated liver disease (“ALD”) is a global health burden with a lack...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.